| Biomarkers for Oral Cancer (NCT00341497) | National Cancer Institute (NCI) | 1996-08-28 |
| Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl Accident (NCT00341016) | National Cancer Institute (NCI) | 1996-08-26 |
| Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394) (NCT00590785) | National Cancer Institute (NCI) | 1996-08-13 |
| Gemcitabine in Treating Children With Refractory Solid Tumors (NCT00005577) | National Cancer Institute (NCI) | 1996-08-01 |
| Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer (NCT00019201) | National Cancer Institute (NCI) | 1996-08-01 |
| Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic Melanoma (NCT00019175) | National Cancer Institute (NCI) | 1996-08-01 |
| Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (NCT00002725) | National Cancer Institute (NCI) | 1996-08-01 |
| Analysis of NF2 Mutations in Radiation-Related Neural Tumors (NCT00340496) | National Cancer Institute (NCI) | 1996-08-01 |
| Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome (NCT00002798) | National Cancer Institute (NCI) | 1996-08-01 |
| Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer (NCT00001507) | National Cancer Institute (NCI) | 1996-07-12 |
| A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor (NCT00001509) | National Cancer Institute (NCI) | 1996-07-01 |
| Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma (NCT00002759) | National Cancer Institute (NCI) | 1996-06-01 |
| A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients (NCT00001504) | National Cancer Institute (NCI) | 1996-05-01 |
| Specimens From Normal Controls (NCT00341211) | National Cancer Institute (NCI) | 1996-04-11 |
| Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma (NCT00019123) | National Cancer Institute (NCI) | 1996-04-01 |
| Immunotoxin in Treating Patients With Leukemia or Lymphoma (NCT00002765) | National Cancer Institute (NCI) | 1996-04-01 |
| A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors (NCT00001502) | National Cancer Institute (NCI) | 1996-04-01 |
| Topotecan in Treating Children With Refractory Leukemia (NCT00002705) | National Cancer Institute (NCI) | 1996-04-01 |
| Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits (NCT00001500) | National Cancer Institute (NCI) | 1996-04-01 |
| Aminocamptothecin in Treating Patients With Refractory or Recurrent Hodgkin's Disease or Non-Hodgkin's Lymphoma (NCT00002745) | National Cancer Institute (NCI) | 1996-04-01 |
| Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia (NCT00019032) | National Cancer Institute (NCI) | 1996-03-01 |
| Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer (NCT00002734) | National Cancer Institute (NCI) | 1996-03-01 |
| Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer (NCT00001499) | National Cancer Institute (NCI) | 1996-03-01 |
| Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer (NCT00019084) | National Cancer Institute (NCI) | 1996-02-01 |
| A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer (NCT00001498) | National Cancer Institute (NCI) | 1996-02-01 |
| Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia (NCT00002704) | National Cancer Institute (NCI) | 1996-01-01 |
| Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer (NCT00001496) | National Cancer Institute (NCI) | 1996-01-01 |
| Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer (NCT00002723) | National Cancer Institute (NCI) | 1996-01-01 |
| Assessment of Attentional Functioning in Children With HIV-1 Infection (NCT00001497) | National Cancer Institute (NCI) | 1995-12-01 |
| Family Study of Head and Neck Cancers in Taiwan (NCT00342147) | National Cancer Institute (NCI) | 1995-11-07 |
| A Phase I Study of Irinotecan (CPT-11) Administered as a Prolonged Infusion in Adult Patients With Solid Tumors (NCT00001495) | National Cancer Institute (NCI) | 1995-11-01 |
| Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer (NCT00019110) | National Cancer Institute (NCI) | 1995-11-01 |
| A Prospective Study of Diet and Cancer in Members of the American Association of Retired Persons (NCT00340015) | National Cancer Institute (NCI) | 1995-10-24 |
| Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer (NCT00003240) | National Cancer Institute (NCI) | 1995-10-01 |
| A Follow-up Study of Women Evaluated and Treated for Infertility (NCT00342446) | National Cancer Institute (NCI) | 1995-10-01 |
| Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer (NCT00001493) | National Cancer Institute (NCI) | 1995-10-01 |
| Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC (NCT00001450) | National Cancer Institute (NCI) | 1995-09-01 |
| A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients (NCT00001449) | National Cancer Institute (NCI) | 1995-09-01 |
| A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer (NCT00001446) | National Cancer Institute (NCI) | 1995-09-01 |
| Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection (NCT00001445) | National Cancer Institute (NCI) | 1995-08-01 |
| The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection (NCT00001448) | National Cancer Institute (NCI) | 1995-08-01 |
| A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms (NCT00001444) | National Cancer Institute (NCI) | 1995-08-01 |
| Esophageal Cancer Genetics Studies (NCT00341276) | National Cancer Institute (NCI) | 1995-07-06 |
| A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection (NCT00001443) | National Cancer Institute (NCI) | 1995-07-01 |
| Vaccine Therapy in Treating Patients With Multiple Myeloma (NCT00019097) | National Cancer Institute (NCI) | 1995-07-01 |
| A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer (NCT00001442) | National Cancer Institute (NCI) | 1995-07-01 |
| Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy (NCT00001440) | National Cancer Institute (NCI) | 1995-07-01 |
| A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province (NCT00339768) | National Cancer Institute (NCI) | 1995-07-01 |
| DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer (NCT00339859) | National Cancer Institute (NCI) | 1995-06-02 |
| A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes (NCT00001438) | National Cancer Institute (NCI) | 1995-06-01 |
| A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant (NCT00001439) | National Cancer Institute (NCI) | 1995-06-01 |
| Trial of Pentoxifylline in Patients With Functional Disability Caused by Radiation-Induced Advanced Regional Fibrosis (NCT00001437) | National Cancer Institute (NCI) | 1995-06-01 |
| Treatment and Natural History Study of Lymphomatoid Granulomatosis (NCT00001379) | National Cancer Institute (NCI) | 1995-05-05 |
| Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (NCT00002649) | National Cancer Institute (NCI) | 1995-05-01 |
| Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Ukraine Following the Chernobyl Accident (NCT00341094) | National Cancer Institute (NCI) | 1995-05-01 |
| A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma (NCT00001436) | National Cancer Institute (NCI) | 1995-05-01 |
| Psychosocial Correlates and Coping Strategies Associated With Long-Term Survival of HIV-Infected Children (NCT00001435) | National Cancer Institute (NCI) | 1995-04-01 |
| Radiation Therapy in Treating Patients With Glioblastoma (NCT00019058) | National Cancer Institute (NCI) | 1995-04-01 |
| Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor (NCT00002643) | National Cancer Institute (NCI) | 1995-04-01 |
| Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study (NCT00342992) | National Cancer Institute (NCI) | 1995-03-03 |
| The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies (NCT00001432) | National Cancer Institute (NCI) | 1995-03-01 |
| Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma (NCT00019071) | National Cancer Institute (NCI) | 1995-03-01 |
| Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma (NCT00002625) | National Cancer Institute (NCI) | 1995-03-01 |
| Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer (NCT00019006) | National Cancer Institute (NCI) | 1995-03-01 |
| A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer (NCT00001426) | National Cancer Institute (NCI) | 1995-02-03 |
| A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas (NCT00001431) | National Cancer Institute (NCI) | 1995-02-01 |
| A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer (NCT00001428) | National Cancer Institute (NCI) | 1995-02-01 |
| A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas (NCT00001430) | National Cancer Institute (NCI) | 1995-02-01 |
| A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin (NCT00001427) | National Cancer Institute (NCI) | 1995-01-01 |
| Molecular Epidemiology of Dioxin-Related Illness in Seveso (NCT00340873) | National Cancer Institute (NCI) | 1994-12-12 |
| Evaluation and Natural History of Children With Cancer and AIDS (NCT00001424) | National Cancer Institute (NCI) | 1994-11-01 |
| Total Body Irradiation for Bone Marrow Transplants: Collaborative Efforts (NCT00026858) | National Cancer Institute (NCI) | 1994-10-01 |
| Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors (NCT00002587) | National Cancer Institute (NCI) | 1994-09-01 |
| Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy (NCT00001387) | National Cancer Institute (NCI) | 1994-09-01 |
| Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia (NCT00002574) | National Cancer Institute (NCI) | 1994-09-01 |
| A Case-Referent Study of Brain Tumors in Adults (NCT00339300) | National Cancer Institute (NCI) | 1994-08-19 |
| Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma (NCT00002556) | National Cancer Institute (NCI) | 1994-07-01 |
| Lymphocyte Therapy in Treating Patients With Kidney Cancer (NCT00002589) | National Cancer Institute (NCI) | 1994-07-01 |
| Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection (NCT00001386) | National Cancer Institute (NCI) | 1994-06-01 |
| Positron Emission Tomography in Patients With Breast Cancer (NCT00001385) | National Cancer Institute (NCI) | 1994-05-01 |
| A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients (NCT00001384) | National Cancer Institute (NCI) | 1994-05-01 |
| Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Belarus Following the Chernobyl Accident (NCT00339716) | National Cancer Institute (NCI) | 1994-03-21 |
| A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder (NCT00001381) | National Cancer Institute (NCI) | 1994-03-01 |
| A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate (NCT00001382) | National Cancer Institute (NCI) | 1994-03-01 |
| A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 (NCT00001383) | National Cancer Institute (NCI) | 1994-03-01 |
| A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer (NCT00001378) | National Cancer Institute (NCI) | 1994-01-01 |
| A Pilot Study of Topical Antiflammin-2 for Psoriasis (NCT00001371) | National Cancer Institute (NCI) | 1993-12-01 |
| Familial Prostate Cancer (NCT00001377) | National Cancer Institute (NCI) | 1993-12-01 |
| Retinoblastoma Biomarker Study (NCT00342797) | National Cancer Institute (NCI) | 1993-11-17 |
| Screening for Lung Cancer in Older Patients (PLCO Screening Trial) (NCT01696968) | National Cancer Institute (NCI) | 1993-11-16 |
| Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial) (NCT01696981) | National Cancer Institute (NCI) | 1993-11-16 |
| Screening for Prostate Cancer in Older Patients (PLCO Screening Trial) (NCT00002540) | National Cancer Institute (NCI) | 1993-11-16 |
| Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial) (NCT01696994) | National Cancer Institute (NCI) | 1993-11-16 |
| Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate (NCT00018967) | National Cancer Institute (NCI) | 1993-11-01 |
| A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease (NCT00001341) | National Cancer Institute (NCI) | 1993-09-01 |
| Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer (NCT00002537) | National Cancer Institute (NCI) | 1993-09-01 |
| A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection (NCT00001339) | National Cancer Institute (NCI) | 1993-08-01 |
| Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides (NCT00002557) | National Cancer Institute (NCI) | 1993-06-01 |
| A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer (NCT00001338) | National Cancer Institute (NCI) | 1993-06-01 |
| A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis (NCT00340821) | National Cancer Institute (NCI) | 1993-05-17 |